These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30315184)

  • 1. Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA.
    Yamamoto T; Sakamoto C; Tachiwana H; Kumabe M; Matsui T; Yamashita T; Shinagawa M; Ochiai K; Saitoh N; Nakao M
    Sci Rep; 2018 Oct; 8(1):15202. PubMed ID: 30315184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Eleanor ncRNAs activate the topological domain of the ESR1 locus to balance against apoptosis.
    Abdalla MOA; Yamamoto T; Maehara K; Nogami J; Ohkawa Y; Miura H; Poonperm R; Hiratani I; Nakayama H; Nakao M; Saitoh N
    Nat Commun; 2019 Aug; 10(1):3778. PubMed ID: 31439835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation.
    Tomita S; Abdalla MOA; Fujiwara S; Matsumori H; Maehara K; Ohkawa Y; Iwase H; Saitoh N; Nakao M
    Nat Commun; 2015 Apr; 6():6966. PubMed ID: 25923108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
    Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
    Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy.
    Zimmermann MC; Tilghman SL; Boué SM; Salvo VA; Elliott S; Williams KY; Skripnikova EV; Ashe H; Payton-Stewart F; Vanhoy-Rhodes L; Fonseca JP; Corbitt C; Collins-Burow BM; Howell MH; Lacey M; Shih BY; Carter-Wientjes C; Cleveland TE; McLachlan JA; Wiese TE; Beckman BS; Burow ME
    J Pharmacol Exp Ther; 2010 Jan; 332(1):35-45. PubMed ID: 19797619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer.
    Bratton MR; Martin EC; Elliott S; Rhodes LV; Collins-Burow BM; McLachlan JA; Wiese TE; Boue SM; Burow ME
    J Steroid Biochem Mol Biol; 2015 Jun; 150():17-23. PubMed ID: 25771071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines.
    Sikora MJ; Jacobsen BM; Levine K; Chen J; Davidson NE; Lee AV; Alexander CM; Oesterreich S
    Breast Cancer Res; 2016 Sep; 18(1):92. PubMed ID: 27650553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer.
    Fukuoka M; Ichikawa Y; Osako T; Fujita T; Baba S; Takeuchi K; Tsunoda N; Ebata T; Ueno T; Ohno S; Saitoh N
    Cancer Sci; 2022 Jul; 113(7):2336-2351. PubMed ID: 35415910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.
    Chan CM; Martin LA; Johnston SR; Ali S; Dowsett M
    J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer.
    Du T; Sikora MJ; Levine KM; Tasdemir N; Riggins RB; Wendell SG; Van Houten B; Oesterreich S
    Breast Cancer Res; 2018 Sep; 20(1):106. PubMed ID: 30180878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors.
    Bacci M; Giannoni E; Fearns A; Ribas R; Gao Q; Taddei ML; Pintus G; Dowsett M; Isacke CM; Martin LA; Chiarugi P; Morandi A
    Cancer Res; 2016 Mar; 76(6):1615-26. PubMed ID: 26795347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.
    Jeng MH; Shupnik MA; Bender TP; Westin EH; Bandyopadhyay D; Kumar R; Masamura S; Santen RJ
    Endocrinology; 1998 Oct; 139(10):4164-74. PubMed ID: 9751496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyceollin I enantiomers distinctly regulate ER-mediated gene expression.
    Payton-Stewart F; Khupse RS; Boué SM; Elliott S; Zimmermann MC; Skripnikova EV; Ashe H; Tilghman SL; Beckman BS; Cleveland TE; McLachlan JA; Bhatnagar D; Wiese TE; Erhardt P; Burow ME
    Steroids; 2010 Dec; 75(12):870-8. PubMed ID: 20493896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol.
    Song RX; Mor G; Naftolin F; McPherson RA; Song J; Zhang Z; Yue W; Wang J; Santen RJ
    J Natl Cancer Inst; 2001 Nov; 93(22):1714-23. PubMed ID: 11717332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyceollins trigger anti-proliferative effects through estradiol-dependent and independent pathways in breast cancer cells.
    Lecomte S; Chalmel F; Ferriere F; Percevault F; Plu N; Saligaut C; Surel C; Lelong M; Efstathiou T; Pakdel F
    Cell Commun Signal; 2017 Jun; 15(1):26. PubMed ID: 28666461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.
    Guest SK; Ribas R; Pancholi S; Nikitorowicz-Buniak J; Simigdala N; Dowsett M; Johnston SR; Martin LA
    PLoS One; 2016; 11(6):e0157397. PubMed ID: 27308830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen can restore Tamoxifen sensitivity in breast cancer cells amidst the complex network of resistance.
    Mansouri S; Farahmand L; Hosseinzade A; Eslami-S Z; Majidzadeh-A K
    Biomed Pharmacother; 2017 Sep; 93():1320-1325. PubMed ID: 28747013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic syntheses and antiproliferative activities of racemic, natural (-), and unnnatural (+) glyceollin I.
    Khupse RS; Sarver JG; Trendel JA; Bearss NR; Reese MD; Wiese TE; Boue SM; Burow ME; Cleveland TE; Bhatnagar D; Erhardt PW
    J Med Chem; 2011 May; 54(10):3506-23. PubMed ID: 21513275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer.
    Maximov PY; Abderrahman B; Fanning SW; Sengupta S; Fan P; Curpan RF; Rincon DMQ; Greenland JA; Rajan SS; Greene GL; Jordan VC
    Mol Pharmacol; 2018 Aug; 94(2):812-822. PubMed ID: 29739819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.